Target Healthcare Reit Ltd

(THRL)
Sector: Closed End Investments
90.30p
1.60p 1.80
Last updated: 14:35:27

1 day chart

6 month chart

DIY Investing
Hargreaves Lansdown - Improve the way you pick shares

Today's buy and sell prices

The price at which you can buy a share or investment. It is usually higher than the bid (sell) price. It’s the price you are being offered. Offer 90.30p
The price at which you can sell a share or investment. It is lower than the offer (buy) price. Bid 90.10p
The difference between the bid and offer prices expressed as a percentage. When you buy shares you pay a higher price than you get when you sell them. The difference between these prices is the profit made by the market maker who puts the deals together. Spread 0.22

Today's trading

Range The lowest and the highest price a share has reached in the trading day. 88.80p-90.70p
The lowest and the highest price a share has reached in the trading day. Volume 867,011.00
The lowest and the highest price a share has reached in the trading day. Today's open 89.90p
At the end of the trading day there is an official closing price for every share. The previous session’s close is used as the base to calculate the following day’s price changes. Previous close 88.70p

Yearly summary

The highest and lowest prices the shares have traded at over a rolling 52-week period. It gives you a good indication of how the share price is performing now relative to its recent past performance. 52wk range 70.80p-90.70p

Fundamentals and health

A measure of the company's worth on the stock market. We display the previous closing share price multiplied by the number of shares in issue. Market capitalisation £543.82
The number of shares a company has in circulation, in millions. Shares in issue 602.24
The main valuation used by investors and a way of gauging whether a company's share price is cheap or expensive compared to competitors. You get PE by dividing the share price by the earnings per share (EPS). Our figure is last basic unadjusted - reported - annual EPS / current share price x 100. Companies also quote adjusted EPS figures to remove the effect of one-off exceptional figures from the profit figures. There is debate among investors as to whether this should be used. We use basic EPS – the purest figure. PE ratio 12
PEG ratio 0.6
An important ratio for showing how much profit after tax and other deductions (net profit) is actually being earned per share. You divide the net profit by the number of shares in issue. Expressed in pence per share. Looking at whether the EPS is rising or falling over time is one of the most important indicators of whether a company is really making money for its shareholders. Our figure is undiluted, meaning it is not adjusted for exceptional costs. EPS 5.85p
Earnings per share growth illustrates the growth of earning per share over the last two reporting periods. It helps investors identify stocks that are increasing or decreasing in profitability. A minus sign indicates negative growth. EPS growth 19
Return on capital employed measures a company's profitability in relation to how much capital is invested in the business. Generally, the higher the figure the better but with all these ratios it is best to compare companies from the same sector. A high double digit figure may mean a company has an advantage over its competitors because of a unique product but an oil company, for example, will have higher capital outlay than an online retailer. Our formula: [Pre-tax profit / (total assets – short-term liabilities)] * 100 ROCE n/a
Also known as the acid test ratio, it's a quick guide to how well a company can pay its short-term debts. Above 1 is considered healthy. A ratio of 1.5 would mean the company has £1.50 of liquid (accessible) assets to cover each £1 of debt (current liabilities). Formula: Current assets minus inventory / current liabilities. Quick ratio n/a
Indicates whether a company can convert assets into cash to pay its debts within the next 12 months. It is calculated as current assets / current liabilities for the same period but will display as '0' for companies such as banks that don't distinguish between short and long-term liabilities. Current ratio 1.36
The amount of money a company paid to a shareholder for each share they own over the past 12 months, expressed in pence. Total dividends per share 2.856p
The dividends paid per share over the past 12 months (interim plus final) as a percentage of the share price. Our figure includes recurring special dividends. Dividend yield 9
The number of times the dividend could have been paid out from net profits. It is a good indicator of the company's ability to pay the dividend and its level of generosity. Formula: earnings per share / dividends per share. More than 2 is considered healthy, less than 1.5 may hint that a dividend is at risk of being cut. Dividend cover 0.93
Dividend per share growth -4.15

Target Healthcare Reit Ltd Fundamentals

Target Healthcare REIT plc is a United Kingdom-based real estate investment company. The Company's investment objective is to provide shareholders with an attractive level of income, together with the potential for capital and income growth, from investing in a diversified portfolio of freehold and long leasehold care homes that are let to care home operators; and other healthcare assets in the United Kingdom. Its portfolio comprised 97 properties let to 32 tenants. The Company invests in modern, purpose-built care homes that are let to tenants who demonstrate operational capabilities and a care ethos. Its portfolio includes Chawley Grove, Roden Hall, The Oaks, Chesterfield, Woodland View and The Manor. The Company invests in a portfolio of care homes, predominantly in the United Kingdom, which are let to care home operators on full repairing and insuring leases.

Target Healthcare Reit Ltd Regulatory news

Target Healthcare Reit Ltd Latest trades

Latest trades

Date Time Price Amount Value Type Buy / sell
19/09/2024 14:16:04 90p 29 £26.10 O Buy
19/09/2024 14:14:05 90p 723 £650.70 AT Sell
19/09/2024 14:14:05 90p 427 £384.30 AT Sell
19/09/2024 13:55:01 90p 1,689 £1,520.10 O Buy
19/09/2024 13:48:04 90p 1,357 £1,221.30 AT Sell

Analysis

Buy Sell Unknown
Quantity 142 92 5
Volume 277,703 232,589 356,719
Value £250,465 £209,111 £320,871

Target Healthcare Reit Ltd Director dealings

Trade date Director Volume / Price Trade value Trade type
26/03/2024 Vince Niblett 24,052 @ 82.69p £19,888.60 Buy
27/03/2023 Richard Cotton 30,000 @ 67.00p £20,100.00 Buy
06/05/2022 Alison Fyfe 10,000 @ 109.80p £10,980.00 Buy
27/02/2018 Gordon Coull 3,454 @ 108.00p £3,730.32 Placing
27/02/2018 Gordon Coull 2,000 @ 108.00p £2,160.00 Placing
27/02/2018 Robert Malcolm Naish 5,000 @ 108.00p £5,400.00 Placing
12/05/2016 Robert Malcolm Naish 10,000 @ 105.00p £10,500.00 Buy
12/05/2016 Thomas J Hutchison III 10,000 @ 105.00p £10,500.00 Buy
26/09/2014 Gordon Coull 19,000 @ 101.00p £19,190.00 Buy
26/09/2014 Robert Malcolm Naish 15,000 @ 101.00p £15,150.00 Buy

Target Healthcare Reit Ltd Broker views

Date Broker Recomm. Old target price New target price Notes
19/10/2022 Berenberg Bank hold 110.00p 90.00p reiteration
31/08/2022 Berenberg Bank hold 120.00p 110.00p reiteration
06/04/2022 Berenberg Bank hold 130.00p 120.00p downgrade
08/11/2021 Berenberg Bank buy 130.00p 130.00p reiteration
Stockopedia: Comprehensive stock market insights